Pacific Biosciences of California Inc’s recent filing unveils that its insider HENRY CHRISTIAN O unloaded Company’s shares for reported $17583.0 on Mar 03 ’25. In the deal valued at $1.41 per share,12,497 shares were sold. As a result of this transaction, HENRY CHRISTIAN O now holds 2,225,357 shares worth roughly $3.09 million.
Then, Van Oene Mark sold 6,486 shares, generating $9,126 in total proceeds. Upon selling the shares at $1.41, the insider now owns 1,497,695 shares.
Before that, Farmer Michele sold 2,973 shares. Pacific Biosciences of California Inc shares valued at $4,183 were divested by the insider at a price of $1.41 per share. As a result of the transaction, Farmer Michele now holds 184,619 shares, worth roughly $0.26 million.
UBS downgraded its Pacific Biosciences of California Inc [PACB] rating to a Neutral from a a Buy in a research note published recently. JP Morgan also remained covering PACB and has decreased its forecast on April 22, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Goldman revised its rating on April 18, 2024. It rated PACB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PACB
On Monday, Pacific Biosciences of California Inc [NASDAQ:PACB] saw its stock jump 4.51% to $1.39. Over the last five days, the stock has gained 5.70%. Pacific Biosciences of California Inc shares have fallen nearly -24.04% since the year began. Nevertheless, the stocks have fallen -66.71% over the past one year. While a 52-week high of $5.01 was reached on 01/08/25, a 52-week low of $1.16 was recorded on 03/07/25. SMA at 50 days reached $1.6528, while 200 days put it at $1.7529.
Levels Of Support And Resistance For PACB Stock
The 24-hour chart illustrates a support level at 1.2933, which if violated will result in even more drops to 1.1967. On the upside, there is a resistance level at 1.4783. A further resistance level may holdings at 1.5667. The Relative Strength Index (RSI) on the 14-day chart is 43.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1389, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.35%. Stochastics %K at 9.44% indicates the stock is a buying.
The most recent change occurred on December 14, 2023 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $11 price target.
